BERLIN, July 24 (Reuters) - Weak demand for glyphosate-based weed killers led Bayer (BAYGn.DE) to cut its full-year earnings outlook for the second time and announce a 2.5 billion euro ($2.8 billion) write-down on glyphosate-related assets.
That was lower than a previous 2023 outlook of 12.5 billion euros, or slightly higher.
Free cash flow would come in at zero, down from a previous prediction of 3 billion euros, the company said.
"Based on the anticipated market development, in particular with respect to the glyphosate business, Bayer also expects to record a goodwill impairment of approximately 2.5 billion euros," it said.
That would result in a second-quarter net loss of 2 billion euros.
Persons:
Bayer, Hurricane Ida, Bill Anderson, Roche, Werner Baumann, Thomas Escritt, Ludwig Burger, Jonathan Oatis, Susan Fenton
Organizations:
Bayer, FMC, BASF, Thomson
Locations:
BERLIN